- Founded
- 2019
- Employees
- 11-50
- Total Funding
- $786.3M
Founded by John J.P. Kastelein in 2019.
About NewAmsterdam Pharma
Founded in 2019 by the venture capital firm Forbion and John Kastelein, NewAmsterdam Pharma is a privately held, clinical-stage company focused on the research and development of transformative therapies for cardiometabolic diseases. Its mission is to improve patient care in populations where traditional therapies are not tolerated or have been unsuccessful.
Leadership at NewAmsterdam Pharma
The team at the top of the org chart.
Michael Davidson
CEO
71 reports
John Kastelein
CSO
1 report
David Topper
Chief Financial Officer
12 reports
Douglas Kling
Chief Operating Officer
15 reports
BJ Jones
Chief Commercial Officer
10 reports
Matthew Philippe
Executive Vice President
18 reports
M. Ian Somaiya
Chief Financial Officer
Marc Ditmarsch
Chief Development Officer
3 reports
Michael Marino
Chief Legal Officer
4 reports
Board
James N. Topper
Board Member
Nicholas Downing
Board Member
Sander Van Slootweg
Board Member
Juliette Audet
Board Member
Lou Lange
Board Member
John Smither
Board Member
Open Jobs at NewAmsterdam Pharma (8)
- NewAmsterdam Pharma · Remote - USA · 2moFull-time
- NewAmsterdam Pharma · Remote - USA · 2moFull-time
- NewAmsterdam Pharma · Remote - USA · 2moFull-time
- NewAmsterdam Pharma · Remote - USA · 2moFull-time
- NewAmsterdam Pharma · Remote - USA · 2moFull-time
- NewAmsterdam Pharma · Remote - Pennsylvania · 2moFull-time
- NewAmsterdam Pharma · Remote - USA · 2moFull-time
- NewAmsterdam Pharma · Remote - USA · 2moFull-time
Similar companies hiring
Top employers in Biotechnology